SageView Advisory Group’s Cidara Therapeutics CDTX Stock Holding History

SageView Advisory Group’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9	Closed	-$1.99K	–	897
2025 Q4	$1.99K	Buy	+9	New	+$1.46K	﹤0.01%	2233

SageView Advisory Group's CDTX Position: Q1 2026 in Review

SageView Advisory Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 9 shares — an estimated $1.99K sold.

SageView Advisory Group first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.99K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

SageView Advisory Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 9 Cidara Therapeutics shares in Q1 2026, an estimated $1.99K.
SageView Advisory Group first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Cidara Therapeutics position peaked at $1.99K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.